ArticleJournal for immunotherapy of cancer2022

Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway.

Yue Zhuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.